Comparison of Small Gut and Whole Gut Microbiota of First-Degree Relatives With Adult Celiac Disease Patients and Controls
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- India
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Duodenum Proximal intestine,Upper intestine,Duodenum,duodenum
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Celiac disease CD - Celiac disease,CD - Coeliac disease,CELIAC DIS,celiac disease,Celiac disease (disorder),Celiac disease NOS,Celiac disease NOS (disorder),Celiac rickets,Celiac rickets (disorder),Celiac Sprue,celiac sprue,Celiac syndrome,Coeliac disease,coeliac disease,Coeliac disease [Ambiguous],Coeliac disease NOS,Coeliac rickets,Coeliac sprue,Coeliac syndrome,CS - Celiac sprue,CS - Coeliac sprue,Disease, Celiac,Enteropathies, Gluten,Enteropathies, Gluten-Sensitive,Enteropathy, Gluten,Enteropathy, Gluten-Sensitive,Gluten Enteropathies,Gluten enteropathy,Gluten Sensitive Enteropathy,Gluten-Induced Enteropathy,gluten-induced enteropathy,Gluten-induced enteropathy syndrome,Gluten-responsive sprue,Gluten-Sensitive Enteropathies,Gluten-Sensitive Enteropathy,GSE - Gluten-sensitive enteropathy,Idiopathic steatorrhea,idiopathic steatorrhea,Idiopathic steatorrhoea,Non Tropical Sprue,non tropical sprue,Non-tropical sprue,Nontropical Sprue,Sprue,Sprue, Celiac,Sprue, Nontropical,Steatorrhoea - idiopathic,Wheat-sensitive enteropathy,Celiac disease
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Disease Control (DC)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- First-degree relatives (FDRs) of celiac disease (CeD) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- First-degree relatives (FDRs) of celiac disease (CeD) patients genetically susceptible to celiac disease (CeD)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 14
- Group 1 sample size Number of subjects in the case (exposed) group
- 13
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- None
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- raw counts
- Statistical test
- DESeq2
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.01
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
Signature 1
Source: Figure 3A
Description: Comparison of differential abundance of microbial ASVs in duodenal microbiota of disease control (DC) group versus First-degree relatives (FDRs)
Abundance in Group 1: increased abundance in First-degree relatives (FDRs) of celiac disease (CeD) patients
Revision editor(s): Temi, Scholastica
Signature 2
Source: Figure 3A
Description: Comparison of differential abundance of microbial ASVs in duodenal microbiota of disease control (DC) group versus First-degree relatives (FDRs)
Abundance in Group 1: decreased abundance in First-degree relatives (FDRs) of celiac disease (CeD) patients
NCBI | Quality Control | Links |
---|---|---|
Turicibacter | ||
Streptococcus | ||
Ruminococcus | ||
Moraxella | ||
Methanomassiliicoccus | ||
Lactobacillus | ||
Intestinibacter | ||
Eubacterium | ||
Blautia | ||
Barnesiella |
Revision editor(s): Temi, Scholastica
Experiment 2
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- First-degree relatives (FDRs) of celiac disease (CeD) patients
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Celiac disease (CeD)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with celiac disease (CeD)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 13
- Group 1 sample size Number of subjects in the case (exposed) group
- 16
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
Signature 1
Source: Figure 3B
Description: Comparison of differential abundance of microbial ASVs in duodenal microbiota of celiac disease versus disease control (DC) group
Abundance in Group 1: increased abundance in Celiac disease (CeD)
NCBI | Quality Control | Links |
---|---|---|
Methanomassiliicoccus | ||
Megasphaera | ||
Lactobacillus | ||
Helicobacter | ||
Eubacterium | ||
Catenibacterium | ||
Blautia | ||
Akkermansia |
Revision editor(s): Scholastica
Signature 2
Source: Figure 3B
Description: Comparison of differential abundance of microbial ASVs in duodenal microbiota of celiac disease versus disease control (DC) group
Abundance in Group 1: decreased abundance in Celiac disease (CeD)
Revision editor(s): Scholastica
Experiment 3
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Disease Control (DC)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 14
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
Signature 1
Source: Figure 3C
Description: Comparison of differential abundance of microbial ASVs in duodenal microbiota of disease control (DC) versus celiac disease (CeD) patients
Abundance in Group 1: increased abundance in Celiac disease (CeD)
NCBI | Quality Control | Links |
---|---|---|
Prevotella | ||
Methanomassiliicoccus | ||
Megasphaera | ||
Lactobacillus | ||
Helicobacter | ||
Catenibacterium | ||
Blautia |
Revision editor(s): Scholastica
Signature 2
Source: Figure 3C
Description: Comparison of differential abundance of microbial ASVs in duodenal microbiota of disease control (DC) versus celiac disease (CeD) patients
Abundance in Group 1: decreased abundance in Celiac disease (CeD)
NCBI | Quality Control | Links |
---|---|---|
Turicibacter | ||
Ruminococcus | ||
Moraxella | ||
Methanomassiliicoccus | ||
Lactobacillus | ||
Intestinibacter | ||
Eubacterium | ||
Blautia | ||
Barnesiella |
Revision editor(s): Scholastica
Experiment 4
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- First-degree relatives (FDRs) of celiac disease (CeD) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Fecal samples of first-degree relatives (FDRs) of celiac disease (CeD) patients genetically susceptible to celiac disease (CeD)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 23
- Group 1 sample size Number of subjects in the case (exposed) group
- 15
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
Signature 1
Source: Figure 5A
Description: Comparison of differential abundance of microbial ASVs in fecal microbiota of disease control (DC) group versus First-degree relatives (FDRs)
Abundance in Group 1: increased abundance in First-degree relatives (FDRs) of celiac disease (CeD) patients
NCBI | Quality Control | Links |
---|---|---|
Methanomassiliicoccus |
Revision editor(s): Scholastica
Signature 2
Source: Figure 5A
Description: Comparison of differential abundance of microbial ASVs in fecal microbiota of disease control (DC) group versus First-degree relatives (FDRs)
Abundance in Group 1: decreased abundance in First-degree relatives (FDRs) of celiac disease (CeD) patients
NCBI | Quality Control | Links |
---|---|---|
Methanomassiliicoccus | ||
Lactobacillus | ||
Haemophilus | ||
Dorea | ||
Akkermansia |
Revision editor(s): Scholastica
Experiment 5
Subjects
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- First-degree relatives (FDRs) of celiac disease (CeD) patients genetically susceptible to celiac disease (CeD)
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
Signature 1
Source: Figure 5B
Description: Comparison of differential abundance of microbial ASVs in fecal microbiota of celiac disease versus disease control (DC) group
Abundance in Group 1: increased abundance in First-degree relatives (FDRs) of celiac disease (CeD) patients
NCBI | Quality Control | Links |
---|---|---|
Methanomassiliicoccus | ||
Lactobacillus |
Revision editor(s): Scholastica
Signature 2
Source: Figure 5B
Description: Comparison of differential abundance of microbial ASVs in fecal microbiota of celiac disease versus disease control (DC) group
Abundance in Group 1: decreased abundance in First-degree relatives (FDRs) of celiac disease (CeD) patients
NCBI | Quality Control | Links |
---|---|---|
Pediococcus | ||
Methanomassiliicoccus | ||
Intestinibacter | ||
Dorea | ||
Blautia |
Revision editor(s): Scholastica
Experiment 6
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- First-degree relatives (FDRs) of celiac disease (CeD) patients
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Celiac disease (CeD)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with celiac disease (CeD)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 15
- Group 1 sample size Number of subjects in the case (exposed) group
- 21
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
Signature 1
Source: Figure 5C
Description: Comparison of differential abundance of microbial ASVs in fecal microbiota of disease control (DC) versus celiac disease (CeD) patients
Abundance in Group 1: increased abundance in Celiac disease (CeD)
NCBI | Quality Control | Links |
---|---|---|
Methanomassiliicoccus | ||
Lactobacillus |
Revision editor(s): Scholastica
Signature 2
Source: Figure 5C
Description: Comparison of differential abundance of microbial ASVs in fecal microbiota of disease control (DC) versus celiac disease (CeD) patients
Abundance in Group 1: decreased abundance in Celiac disease (CeD)
NCBI | Quality Control | Links |
---|---|---|
Prevotella | ||
Methanomassiliicoccus | ||
Lactobacillus | ||
Dorea | ||
Akkermansia |
Revision editor(s): Scholastica